Jul 23, 2021 - In this short video, Professor Jean-Michel Molina of Hôpital Saint-Louis in Paris talks to NAM aidsmap's Roger Pebody about injectable lenacapavir, a capsid inhibitor currently under development, for people with multidrug-resistant HIV. Research on lenacapavir was presented at the recent International AIDS Society Conference on HIV Science (IAS 2021).
